drugset / Trial / NCT00104637

Sildenafil for Chronic Obstructive Pulmonary Disease

NCT00104637

Phase 2 Completed 10 enrolled Kawut, Steven, MD Pfizer · collab
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine if sildenafil improves the exercise capacity and lung function of patients with chronic obstructive pulmonary disease.

Timeline

Start
2005-02
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 25 mg Oral

Indications